$AVTR $BRKR $ILMN $TMO $MRNA $BNTX $SNY $REGN $AMGN $IONS $ARWR $IONS $UTHR $AZN $BMY $LLY $NUVL $SMMT $ABBV $DSNKY Listen to NIH Budget; Moderna’s Covid Gloom; Ionis sHTG Data: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud on.soundcloud.com/6UFINsXkeXiOEw…

On today’s #BiotechHangout, Chris Garabedian, Tess Cameron, Eric Schmidt, Sam Fazeli, & Brad Loncar cover deals/financing: $LBRX IPO (first since Feb), $TRML acquisition, policy: the latest in China biotech: Washington’s response, deals under scrutiny & stakeholder pushback, plus

From oncology to obesity and China $BNTX $BNY $SMMT $DSNKY $ABBV $MRK $AMGN $AZN $NUVL $SGBCF $RVMD $NVO $LLY $MTSR $REGN Listen to WCLC Wrap; Novo Restructuring; Washington News: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud on.soundcloud.com/5cvhZF4txDZGR5…

Sam Fazeli spotlighted Henlius' serplulimab as a "globally recognized" therapy, ranking above peers in ESMO MCBS for ES-SCLC. Now in a U.S. head-to-head trial, he stressed U.S. patients deserve access to the best treatments.

I am in the thick of the ⁦Myeloma Society⁩ conference in Toronto and Carvykti is featuring large. Here is a conversation with CEO of $LEGN Ying Huang ⁦Legend Biotech⁩ - remember this drug that is curing some patients came from China. podcasts.apple.com/gb/podcast/van…

Excellent as usual - if the likes of $EXAS Cancergurad test becomes standard practice and early cancer detection becomes the norm for folks who can afford it - the treatment of solid tumors becomes much more focused on adjuvant and neo-adjuvant therapy. podcasts.apple.com/gb/podcast/van…

Amazing value creation again by ⁦Clive Meanwell⁩ $MTSR $PFE

Join us for a fantastic conversation on Friday at 12 EST after a great week for biotech. $XBI close to the magic 100 point level after a series of positive data readouts and an M&A deal to boot. $MTSR $PFE $MBX $QURE

On today’s #BiotechHangout, Sam Fazeli, Eric Schmidt, Paul Matteis, Brian Skorney & Brad Loncar recap the positive week for biotech, $XBI, offerings & deals: $QURE (+ Huntington’s disease data), $MBX, $IMRX (+ $SNY adds $25M), $PFE/$MTSR $4.9B deal, more data: $MBX in chronic

Well done to my colleague senior analyst ⁦Matt Henriksson. This is an excellent podcast and a must listen for those wondering how machine learning and AI is helping medical progress. podcasts.apple.com/gb/podcast/van…

This is brilliant podcasts.apple.com/gb/podcast/the…

Better late than never, better never late :-) $MRK $BMY $GILD $GSK $PFE $AZN $AMGN $JNJ $NVS $RHHBY $GMAB $MRUS $EXEL Listen to IRA Guidance; Trump/Pfizer Agreement; Genmab Deal: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud on.soundcloud.com/YThI4KMAG24Lw7…

Tess Cameron Brian Skorney Sam Fazeli Yaron Werber Luba Greenwood Daphne Zohar Grace E. Colón, Ph.D. (she/her/they) John Maraganore 🇺🇸🇬🇷🇺🇦 Nina Kjellson Brad Loncar Bruce Booth Tim Opler On $AKRO and $NVO in #MASH, Sam Fazeli says, “When you look at the entirety of the trial, it was strong, better than what we've seen with some of the others and of course, continued to evolve and get better over time. It looks better on efficacy than what $NVO had themselves…

$NOV $AKRO $PFE $BBIO $ALNY $IONS $RNA $DYN $GILD $NOVN $AZN $MRK $DSNKY $RHHBY $LLY $IPSEY $TAK $HCM $BAYRY Listen to ESMO Preview; Cardio Rivalry; DM1 Race: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud on.soundcloud.com/ToCXr0c90F3PKV…

$AZN $PFE $LLY $GILD $NVO $GSK $JNJ $GMAB $MRUS $ZLDPF $RHHBY $MTSR $ABBV $MRK $NVS $SNN $ZBH Listen to Washington, J&J Orpho Spin, Eyecare, Merus Deal: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud on.soundcloud.com/u8g5cQycDG6xft…

So - the discussant for Harmoni-6 referred to a G5 due to bleeding - but we can’t find it in the NEJM paper. What happening? $SMMT

Join me and the team from Leerink and Asthika Goonewardene for a review of ESMO - Eur. Oncology data in 2 hours. bloomberg.zoom.us/webinar/regist…

Et viola: a replay of our Post-ESMO review with Leerink and Truist bloomberg.com/professional/i…

On today’s #BiotechHangout, Chris Garabedian, Brian Skorney, and Sam Fazeli will kick off with general market sentiment & green shoots for biotech, plus public & VC markets, deals/financings: $ALKS/$AVDL $2.1B deal for #narcolepsy drug, $SMMT’s $500M raise w/ 50% insiders, $ANRO &

Hot off the heels of ⁦ESMO - Eur. Oncology⁩ here is a conversation with Susan Galbraith of $AZN - we had a tonne to talk about podcasts.apple.com/gb/podcast/van…